Ascendis Pharma AS

For the period ended Dec 31, 2023. Filed Feb 7, 2024.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2023 · Filed Feb 7, 2024

ASND$259.85+1.2%Stored close · as of Nov 9, 2026

Opening this filing…